RVPH
Reviva Pharmaceuticals Holdings Inc.
NASDAQ: RVPH · HEALTHCARE · BIOTECHNOLOGY
$0.87
+0.43% today
Updated 2026-04-30
Market cap
$11.68M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.48
Dividend yield
—
52W range
$1 – $23
Volume
1.6M
Reviva Pharmaceuticals Holdings Inc. (RVPH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.07M | $-218444.00 | $-4.07M | $-10.67M | $-18.96M | $-28.32M | $-33.54M | $-24.59T |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $21054.00 | $0.00 | $0.00 | $106713.00 | $176735.00 | $3.41M | $1.63M | $2.23T |
| Free cash flow | $-1.07M | $-218444.00 | $-4.07M | $-10.67M | $-18.96M | $-28.32M | $-33.54M | $-24.59T |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |